Quantcast

Latest pharmaceutical industry Stories

2014-07-24 16:27:46

DUBLIN, July 24, 2014 /PRNewswire/ -- -- Advances Endo's transformation into a leading global specialty healthcare company -- Establishes a platform for growth in key Latin American emerging markets -- Norbert Oppitz appointed Regional President, Latin America, Africa and Export Markets Endo International plc (NASDAQ: ENDP) (TSX: ENL) announced today that it has completed the acquisition of Grupo Farmaceutico Somar(®) (Somar), a leading, privately owned...

2014-07-24 12:28:04

DUBLIN, July 24, 2014 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug Administration (FDA) for its previously approved New Drug Application (NDA) for testosterone gel 1.0%. FDA concluded that Perrigo's testosterone product is therapeutically equivalent to [AbbVie's] AndroGel 1% and can be substituted with the full expectation that it will produce the same clinical effect and safety...

2014-07-24 12:27:34

MUMBAI, India, July 24, 2014 /PRNewswire/ -- Consolidated Net Profit increased by 43.65 % to Rs. 1848.46 Mn Business Highlights - India Business grew by 20.87% to Rs. 3,971.59 Mn - US Business grew by 9.33% to Rs. 4,886.70 Mn - Rest of World (ROW) Business grew by 20.67% to Rs. 2,113.09 Mn - Europe Formulations Business grew by 34.53% to Rs. 977.26 Mn - Latin America Business grew by 33.92% to Rs. 1,176.45 Mn...

2014-07-24 08:35:27

BETHESDA, Md., July 24, 2014 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) announced today that 31 of its Training and Research Institute (TRI) courses are now listed with the U.S. General Services Administration (GSA) under a Federal Supply Schedule contract. http://photos.prnewswire.com/prnvar/20130226/DC66667LOGO The 31 courses will be included on the GSA Advantage, GSA's online shopping and ordering system https://www.gsaadvantage.gov/advantage/main/start_page.do)....

2014-07-24 08:33:04

SAN DIEGO, July 24, 2014 /PRNewswire/ -- MedVantx, Inc., the company that has built an innovative new direct-to-consumer prescription delivery channel in physician offices, MedStart Connect, today announced it eliminates many of the underlying issues related to medication non-adherence and hospital readmission rates specified in a study published in a recent issue of the Annals of Internal Medicine. In the study, researchers reported that frequent changes in generic medication pill...

2014-07-24 08:31:56

The Shared Investigator Platform, Built as an Industry Utility, Will Help Accelerate the Development of New Medicines TEANECK, N.J., July 24, 2014 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with...

2014-07-23 23:17:53

MarketReportsOnline.com adds "Global Molecular Diagnostics Market Report: 2014 Edition" report to its research store. Dallas, Texas (PRWEB) July 22, 2014 Over the years, medical science has made unprecedented progress in almost every sphere of human anatomy. In the pursuit, pathological sciences, in particular, have brought forth advancements that rendered the possibility of deploying certain tests that are performed on patient samples, including blood and tissues, in order to...

2014-07-23 23:04:12

One of California’s leading Medicaid plans adopts SafeUseNow to quickly identify and help stop prescription drug abuse ENCINITAS, Calif. (PRWEB) July 23, 2014 SafeUseNow℠, a prescription drug abuse risk identification and intervention program developed by Principled Strategies, today announced a service agreement with Partnership HealthPlan of California. Utilizing SafeUseNow’s patent-pending risk model, Partnership HealthPlan can quickly identify patients at risk of misusing and...

2014-07-23 16:26:42

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Partial Seizure Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243634/Partial-Seizure-Global-Clinical-Trials-Review-H2-2014.htmlPartial Seizure Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Partial Seizure Global Clinical Trials Review, H2, 2014" provides data on the Partial Seizure clinical trial scenario. This report provides...

2014-07-23 16:26:38

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Neonatal Seizures Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243633/Neonatal-Seizures-Global-Clinical-Trials-Review-H2-2014.htmlNeonatal Seizures Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related